Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesMolecular ImagingPSMA-PET predicts patient responses to Ac-225-based RPTThe finding is an important step for further development of new treatment for advanced metastatic prostate cancer.CTAI improves radiologists' performance for identifying lung cancer on CTUltrasoundNew Pitt institute to bring imaging insights from space to EarthWomens ImagingWomen's Imaging MinnieCast, Episode 1 - Amy Patel and 'radvocacy'Womens ImagingAI-mammography finds more interval cancers, reduces workload
